XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) in Treating Melanoma Prior Immune Checkpoint Inhibitor Therapy
Clinical trial NCT05695898 · TERMINATED
Trial details
- NCT number
- NCT05695898
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-28
- Primary completion
- 2024-04-29
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.